Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
N/A
-1,505 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
N/A
1,499 Added 24983.33%
1,505 $5,000
Q4 2020

Feb 11, 2021

SELL
N/A
-76 Reduced 92.68%
6 $0
Q3 2020

Nov 12, 2020

SELL
N/A
-1,289 Reduced 94.02%
82 $0
Q2 2020

Jul 31, 2020

SELL
N/A
-6,285 Reduced 82.09%
1,371 $1,000
Q1 2020

May 01, 2020

BUY
N/A
7,653 Added 255100.0%
7,656 $6,000
Q4 2019

Feb 14, 2020

SELL
N/A
-601 Reduced 99.5%
3 $0
Q3 2019

Nov 14, 2019

BUY
N/A
604 New
604 $2,000

About Altamira Therapeutics Ltd.


  • Ticker EARS
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,869,600
  • Market Cap $39.2M
More about EARS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.